Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.

Patients in England with a form of breast cancer will be offered a new treatment after it was given the green light for NHS use. The Institute of Cancer Research, London, (ICR) – which worked on ...

and now certain breast cancer patients can benefit from the drug on the NHS. “It’s fantastic news that olaparib has been approved for use on the NHS in England, providing a second targeted ...

While breast cancer is rare in men, the disease can affect men too. Men can also have breast lumps and should get a prompt medical evaluation for any lump or change in the appearance of their chest or ...

Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to ...

Bishal Gyawali, MD, PhD, and Sharon Batt, PhD, explore why overall survival continues to be the most patient-centric marker of clinical benefit.

Patients in England with a form of breast cancer will be offered a new treatment after it was given the green light for NHS use. The Institute of Cancer Research, London, (ICR) – which worked on the ...

It usually develops beneath the skin. While an armpit lump can be a symptom of breast cancer, it is not usually the first sign of breast cancer. Instead, the most common symptom of breast cancer is a ...

If you have breast cancer, you will have changes in your breast. These may be lumps or changes in the size or color of your breast, or changes in the appearance of your nipples. Breast cancer ...

Breast cancer is caused by the development of malignant cells in the breast. The malignant cells originate in the lining of the milk glands or ducts of the breast (ductal epithelium). Breast ...